Myositis Advances in Therapy

Myositis Advances in Therapy is organized by Cleveland Clinic Center for Continuing Education.

Release date: August 9, 2019
Expiration date: August 9, 2021

Target Audience:
The online series is designed for rheumatologists, dermatologists, gastroenterologists, infectious disease physicians, pulmonologists, neurologists, oncologists, ophthalmologists, internal medicine physicians, and allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in complex multiorgan autoimmune and autoinflammatory diseases.

Accreditation:
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
In the Biologic Therapies VIII: The Intersection of Rheumatology and Allied Specialties online series, an international, multi-disciplinary faculty of experts focuses on interdisciplinary rheumatology by exploring the interface of rheumatology with disciplines such as infectious disease, gastroenterology, neurology, oncology, dermatology, pulmonology, ophthalmology, and wellness.

Myositis Advances in Therapy webcast highlights advances in myositis treatment, with a focus on biologic therapies.

Learning Objectives:
• Discuss selected clinical features of myositis classification
• Discuss advances in myositis treatment focusing on biologics